![Rajiv Khosla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rajiv Khosla
Amministratore Delegato presso Enteris BioPharma, Inc.
Posizioni attive di Rajiv Khosla
Società | Posizione | Inizio | Fine |
---|---|---|---|
Enteris BioPharma, Inc.
![]() Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Amministratore Delegato | - | - |
Storia della carriera di Rajiv Khosla
Precedenti posizioni note di Rajiv Khosla
Società | Posizione | Inizio | Fine |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. | Direttore/Membro del Consiglio | 24/05/2011 | 15/07/2014 |
Amministratore Delegato | 31/12/2013 | 15/07/2014 | |
Presidente | 31/12/2013 | 15/07/2014 | |
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Direttore/Membro del Consiglio | 18/05/2011 | 18/08/2012 |
Presidente | 18/05/2011 | 18/08/2012 | |
SENSIENT TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
Intelgenx Corp.
![]() Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Direttore/Membro del Consiglio | - | 29/04/2013 |
Amministratore Delegato | 03/01/2014 | - | |
Direttore operativo | - | 03/01/2014 | |
Direttore Tecnico/Scientifico/R&S | - | 03/01/2014 | |
Presidente | 03/01/2014 | - |
Formazione di Rajiv Khosla
Henley Business School Ltd. | Masters Business Admin |
The University of Nottingham | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Regno Unito | 3 |
Canada | 3 |
Posizioni
Director/Board Member | 3 |
President | 3 |
Chief Executive Officer | 3 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SENSIENT TECHNOLOGIES CORPORATION | Consumer Non-Durables |
INTELGENX TECHNOLOGIES CORP. | Health Technology |
Aziende private | 3 |
---|---|
Intelgenx Corp.
![]() Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
Enteris BioPharma, Inc.
![]() Enteris BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Enteris BioPharma, Inc. operates as a clinical stage biopharmaceutical company. It offers formulation solutions built around its proprietary oral drug delivery technologies. The company was founded in 2013 and is headquartered in Boonton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Rajiv Khosla
- Esperienza